PHIO PHARMACEUTICALS CORP. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
PHIO PHARMACEUTICALS CORP. (PHIO) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $491.00 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2014-05-14
- PHIO PHARMACEUTICALS CORP. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2014-03-31 was $491.00K, a 21.82% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2013-06-30 was $429.00K.
- PHIO PHARMACEUTICALS CORP. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2013-03-31 was $628.00K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2014-03-31 | $491.00K 10-Q · filed 2014-05-14 | ||
| 2013-06-30 | $429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $1.06M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $628.00K 10-Q · filed 2014-05-14 | ||
| 2012-12-31 | $968.00K 10-Q · filed 2013-08-14 | ||
| 2011-12-31 | $1.99M 10-Q · filed 2013-08-14 | ||
| 2010-12-31 | $4.37M 10-Q · filed 2013-08-14 | ||
| 2009-12-31 | $4.20M 10-Q · filed 2013-08-14 | ||
| 2008-12-31 | $3.82M 10-Q · filed 2013-08-14 | ||
| 2007-12-31 | $1.81M 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |